Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 25'th Jul 2024
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Labcorp Declares Quarterly Dividend
06:59am, Thursday, 25'th Jul 2024
BURLINGTON, N.C., July 25, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a ca
Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release
10:30am, Monday, 22'nd Jul 2024
Labcorp's (LH) second-quarter 2024 performance is expected to reflect the robust execution of strategic priorities and solid business performances.
Here's Why Labcorp (LH) is a Strong Value Stock
11:01am, Tuesday, 09'th Jul 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?
09:40am, Tuesday, 02'nd Jul 2024
Labcorp's (LH) concentrated development in high-growth areas and strategic partnerships appear encouraging.
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
07:00am, Monday, 01'st Jul 2024
BURLINGTON, N.C. , July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
08:00am, Monday, 17'th Jun 2024
Suite of digital and data solutions designed to improve clinical trial efficiency, reduce data delays and simplify investigator site workflows BURLINGTON, N.C. , June 17, 2024 /PRNewswire/ -- Labcorp
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
07:00am, Monday, 03'rd Jun 2024
Labcorp® Tissue Complete, a comprehensive genomic profiling service, now available in Geneva and Shanghai to support global clinical trials Company expands leadership in liquid biopsy comprehensive g
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
07:00am, Thursday, 30'th May 2024
Abstracts offer insights into precision oncology diagnostics for triple-negative breast cancer, liquid biopsy and machine learning for tumor profiling BURLINGTON, N.C. , May 30, 2024 /PRNewswire/ --
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
06:59am, Tuesday, 28'th May 2024
BURLINGTON, N.C., May 28, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team w
Why Labcorp (LH) is a Top Value Stock for the Long-Term
10:46am, Tuesday, 21'st May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Foundations Investment Advisors LLC Buys Shares of 1,214 Laboratory Co. of America Holdings (NYSE:LH)
07:56am, Monday, 20'th May 2024
Foundations Investment Advisors LLC bought a new position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the 4th quarter, according to the company in its most rec
Labcorp (LH) to Assess Preeclampsia Risk With New Test
10:51am, Thursday, 16'th May 2024
Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy
08:00am, Wednesday, 15'th May 2024
Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters BURLINGTON, N.C. , May 15, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and co
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
11:46am, Thursday, 09'th May 2024
Investors are optimistic about Labcorp (LH), led by strategic acquisitions and strong expansion in the Biopharma Laboratory.
